FDA published a revision to MAPP


Click on the link below to read about how the FDA published a revision to the Manual of Policies and Procedures on ANDAs to ensure fairness to applicants and much more..

FDA revises generic drug application prioritization


And after you read about the revision head on over to Compliance Insight to see how we can help you with all of your FDA filings!


10 views

Gain Our Insight

LET'S GET STARTED

Be in Touch

 

e. info@compliance-insight.com

p. (513) 860 - 3512

© 2020 by Compliance Insight

All Rights Reserved  |  Contact Us

Corporate Headquarters

 

497 Circle Freeway Suite 230

Cincinnati, Ohio 45246

Business Hours

 

Monday - Friday 

8:30am EST - 5:30pm EST

  • facebook
  • linkedin
  • twitter
  • youtube